Clinical Trial Update: Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream. [Phase 3]

View source ↗

Summary

Phase 3 study evaluating real-world use of an adhesive skin patch (Oxytrol) delivering oxybutynin for overactive bladder; status completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• OXYTROL (OXYBUTYNIN)

Snippet

Sponsor: Bayer | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2020-10-20